|
| 36097168 | Prospective comparison of restriction spectrum imaging and non-invasive biomarkers to predict upgrading on active surveillance prostate biopsy. | Prostate Cancer Prostatic Dis | 2024 |
| 38079361 | Reply to "Contextualizing racial associations in prostate cancer to expose structural causes". | Cancer | 2024 |
| 36732203 | Expression of SATB2 in primary cutaneous sarcomatoid neoplasms: a potential diagnostic pitfall. | Pathology | 2023 |
| 37698493 | Racial differences in serum chemokines in prostate cancer patients. | Cancer | 2023 |
| 37644036 | Loss of LCMT1 and biased protein phosphatase 2A heterotrimerization drive prostate cancer progression and therapy resistance. | Nat Commun | 2023 |
| 36585434 | MyProstateScore in men considering repeat biopsy: validation of a simple testing approach. | Prostate Cancer Prostatic Dis | 2023 |
| 34753659 | Association of MyProstateScore (MPS) with prostate cancer grade in the radical prostatectomy specimen. | Urol Oncol | 2022 |
| 35565427 | Shifting the Soil: Metformin Treatment Decreases the Protumorigenic Tumor Microenvironment in Epithelial Ovarian Cancer. | Cancers (Basel) | 2022 |
| 36102613 | PRAME expression in spindle cell melanoma, malignant peripheral nerve sheath tumour, and other cutaneous sarcomatoid neoplasms: a comparative analysis. | Histopathology | 2022 |
| 36386297 | Assessment of prostate cancer progression using a translational needle photoacoustic sensing probe: Preliminary study with intact human prostates <i>ex-vivo</i>. | Photoacoustics | 2022 |
| 33812851 | Development of a Whole-urine, Multiplexed, Next-generation RNA-sequencing Assay for Early Detection of Aggressive Prostate Cancer. | Eur Urol Oncol | 2022 |
| 34906585 | Urinary MyProstateScore (MPS) to Rule out Clinically-Significant Cancer in Men with Equivocal (PI-RADS 3) Multiparametric MRI: Addressing an Unmet Clinical Need. | Urology | 2022 |
| 34993496 | Genetic Factors Associated with Prostate Cancer Conversion from Active Surveillance to Treatment. | HGG Adv | 2022 |
| 35050902 | Collision tumors revealed by prospectively assessing subtype-defining molecular alterations in 904 individual prostate cancer foci. | JCI Insight | 2022 |
| 32631746 | Serial Molecular Profiling of Low-grade Prostate Cancer to Assess Tumor Upgrading: A Longitudinal Cohort Study. | Eur Urol | 2021 |
| 33547200 | Virus-positive Merkel Cell Carcinoma Is an Independent Prognostic Group with Distinct Predictive Biomarkers. | Clin Cancer Res | 2021 |
| 33727260 | A Randomized Phase II Study of Androgen Deprivation Therapy with or without Palbociclib in RB-positive Metastatic Hormone-Sensitive Prostate Cancer. | Clin Cancer Res | 2021 |
| 34738088 | Autophagy Inhibition by Targeting PIKfyve Potentiates Response to Immune Checkpoint Blockade in Prostate Cancer. | Nat Cancer | 2021 |
| 34513230 | Characterizing the aggressiveness of prostate cancer using an all-optical needle photoacoustic sensing probe: feasibility study. | Biomed Opt Express | 2021 |
| 34454112 | Development and Validation of StrataNGS, a Multiplex PCR, Semiconductor Sequencing-Based Comprehensive Genomic Profiling Test. | J Mol Diagn | 2021 |
| 34476329 | Real-World Performance of a Comprehensive Genomic Profiling Test Optimized for Small Tumor Samples. | JCO Precis Oncol | 2021 |
| 34337531 | Association of Urinary MyProstateScore, Age, and Prostate Volume in a Longitudinal Cohort of Healthy Men: Long-term Findings from the Olmsted County Study. | Eur Urol Open Sci | 2021 |
| 33080150 | Use of the MyProstateScore Test to Rule Out Clinically Significant Cancer: Validation of a Straightforward Clinical Testing Approach. | J Urol | 2021 |
| 31420496 | <sup>18</sup>F-Choline PET/mpMRI for Detection of Clinically Significant Prostate Cancer: Part 1. Improved Risk Stratification for MRI-Guided Transrectal Prostate Biopsies. | J Nucl Med | 2020 |
| 33137064 | Photoacoustic spectral analysis at ultraviolet wavelengths for characterizing the Gleason grades of prostate cancer. | Opt Lett | 2020 |
| 32777370 | Impact of the MyProstateScore (MPS) Test on the Clinical Decision to Undergo Prostate Biopsy: Results From a Contemporary Academic Practice. | Urology | 2020 |
| 32299640 | Next-generation RNA Sequencing-based Biomarker Characterization of Chromophobe Renal Cell Carcinoma and Related Oncocytic Neoplasms. | Eur Urol | 2020 |
| 32165916 | Is the HERV-K HML-2 Xq21.33, an endogenous retrovirus mutated by gene conversion of chromosome X in a subset of African populations, associated with human breast cancer? | Infect Agent Cancer | 2020 |
| 32371391 | The role of the histone H3 variant CENPA in prostate cancer. | J Biol Chem | 2020 |
| 30610106 | Multiclonality and Marked Branched Evolution of Low-Grade Endometrioid Endometrial Carcinoma. | Mol Cancer Res | 2019 |
| 31638990 | Plasmacytoid urothelial carcinoma: a rapid autopsy case report with unique clinicopathologic and genomic profile. | Diagn Pathol | 2019 |
| 30239030 | Neurofilament is superior to cytokeratin 20 in supporting cutaneous origin for neuroendocrine carcinoma. | Histopathology | 2019 |
| 31466944 | CDK7 Inhibition Suppresses Castration-Resistant Prostate Cancer through MED1 Inactivation. | Cancer Discov | 2019 |
| 31376196 | Characterization of glycine-N-acyltransferase like 1 (GLYATL1) in prostate cancer. | Prostate | 2019 |
| 28840857 | Detection of 6 TFEB-amplified renal cell carcinomas and 25 renal cell carcinomas with MITF translocations: systematic morphologic analysis of 85 cases evaluated by clinical TFE3 and TFEB FISH assays. | Mod Pathol | 2018 |
| 29956356 | A five-CpG DNA methylation score to predict metastatic-lethal outcomes in men treated with radical prostatectomy for localized prostate cancer. | Prostate | 2018 |
| 30291535 | Association of ERG/PTEN status with biochemical recurrence after radical prostatectomy for clinically localized prostate cancer. | Med Oncol | 2018 |
| 30285995 | VSTM2A Overexpression Is a Sensitive and Specific Biomarker for Mucinous Tubular and Spindle Cell Carcinoma (MTSCC) of the Kidney. | Am J Surg Pathol | 2018 |
| 29744932 | Expression and role of PAICS, a de novo purine biosynthetic gene in prostate cancer. | Prostate | 2018 |
| 29570566 | Nerve Growth Factor and Selected Cytokines in Women With and Without Vulvodynia. | J Low Genit Tract Dis | 2018 |
| 29589155 | Accuracy of tumor segmentation from multi-parametric prostate MRI and <sup>18</sup>F-choline PET/CT for focal prostate cancer therapy applications. | EJNMMI Res | 2018 |
| 29261439 | Targeting Androgen Receptor and DNA Repair in Metastatic Castration-Resistant Prostate Cancer: Results From NCI 9012. | J Clin Oncol | 2018 |
| 29079178 | The utility of SDHB and FH immunohistochemistry in patients evaluated for hereditary paraganglioma-pheochromocytoma syndromes. | Hum Pathol | 2018 |
| 27550065 | Expression and Role of PAICS, a De Novo Purine Biosynthetic Gene in Prostate Cancer. | Prostate | 2017 |
| 28302759 | Preclinical Evaluation of <sup>11</sup>C-Sarcosine as a Substrate of Proton-Coupled Amino Acid Transporters and First Human Application in Prostate Cancer. | J Nucl Med | 2017 |
| 28288038 | Immunohistochemical Characterization of Fumarate Hydratase (FH) and Succinate Dehydrogenase (SDH) in Cutaneous Leiomyomas for Detection of Familial Cancer Syndromes. | Am J Surg Pathol | 2017 |
| 28783718 | Integrative clinical genomics of metastatic cancer. | Nature | 2017 |
| 28753826 | Programmed Death-ligand 1 Expression in Upper Tract Urothelial Carcinoma. | Eur Urol Focus | 2017 |
| 28606924 | Age and Gender Associations of Virus Positivity in Merkel Cell Carcinoma Characterized Using a Novel RNA <i>In Situ</i> Hybridization Assay. | Clin Cancer Res | 2017 |
| 28520829 | Association Between Combined TMPRSS2:ERG and PCA3 RNA Urinary Testing and Detection of Aggressive Prostate Cancer. | JAMA Oncol | 2017 |